Covered recipient · General Payments record
LINDA M BOTT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$763.91
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $162.85 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $66.96 | 4 |
| PFIZER INC. | $27.97 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.27 | 1 |
| Novo Nordisk AS | $16.97 | 1 |
| Acerta Pharma LLC | $16.73 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.05 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803655 | CMS |
| ABBVIE INC. | $16.87 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803657 | CMS |
| ABBVIE INC. | $16.18 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803659 | CMS |
| ABBVIE INC. | $18.86 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106803661 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.73 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104325270 | CMS |
| Novartis Pharmaceuticals Corporation | $19.27 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086777359 | CMS |
| Novo Nordisk Inc | $16.97 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100499715 | CMS |
| PFIZER INC. | $14.09 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131138286 | CMS |
| PFIZER INC. | $13.88 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131956609 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.95 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137716271 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.